Eton Pharmaceuticals (ETON) Stock Looks Above Fair Value On Earnings
Eton Pharmaceuticals (ETON) Unveils ET 900 And Shares Early ET 700 Clinical Data
Witnessing An Insider Decision, CHARLES CASAMENTO Exercises Options Valued At $4.99M At Eton Pharmaceuticals
Is Eton Pharmaceuticals (ETON) Still Below Fair Value As Earnings And Guidance Impress?
B. Riley Securities Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $81
Why Eton Pharmaceuticals Stock Is Up 19.7% And What's Next
Canaccord Genuity Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $80
HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $80
Eton Q3 Earnings Call Highlights Growth and Pipeline Expansion
Eton Pharma (ETON) Q3 2026 Earnings Call Transcript
Eton Pharmaceuticals Inc (ETON) (Q3 2026) Earnings Call Highlights: Record Revenue, Raised ...
Eton Pharmaceuticals Q3 Earnings Call Highlights
Eton Pharmaceuticals (NASDAQ:ETON) Surges on Q3 Beat and Raised Guidance
Eton Pharmaceuticals Reports Third Quarter 2026 Financial Results
Eton Pharmaceuticals, Inc. (ETON) Q3 2026 Earnings Call Transcript
Eton Pharmaceuticals Announces Preliminary ET-700 Pilot Study Results Evaluating Copper Absorption Inhibition and Gastrointestinal Tolerability
Eton Pharmaceuticals Q3 2026 Earnings Call Transcript
Eton Pharmaceuticals FY2026 Revenue expected to be more than $175.000M vs $149.702M Est
Eton Pharmaceuticals Announces Its ET-700 Zing Acetate Formulation Shows Lower Rate Of Drug Related Adverse Events In Pilot Trial Than GALZIN; No Serious Adverse Events Seen
Eton Pharmaceuticals to Present at 2026 Jefferies Global Healthcare Conference in London
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.